Report Highlights
The global clinical infant nutrition market reached $44.8 billion in 2021 and should reach more than $61.5 billion by 2026, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2021-2026.
Report Includes
- 17 data tables and 32 additional tables
- An up-to-date overview and analysis of the global market for clinical infant nutrition
- Analyses of the global market trends, with historical sales data for 2018-2021, and projections of compound annual growth rates (CAGRs) through 2026
- Highlights of the current and future market potential for clinical infant nutrition, and areas of focus to forecast this market into various segments and sub-segments
- Evaluation and forecast the clinical infant nutrition market size, projected growth trends, and corresponding market share analysis segmented by nutrition type, formulation technique, product form, and geographic region
- Assessment of major driving factors, trends, opportunities and challenges in this innovation driven market, along with technology advances and regulatory implications within the marketplace
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
- Company profiles of major players within the industry, including Abbott Laboratories, Baxter International Inc., Danone, Fresenius, Nestlé, and Reckitt Benckiser Group Plc
Report Scope
The current report will provide detailed information regarding the infant nutrition market. It analyzes the market trends of infant nutrition with data from 2020, estimates from 2021, projections of compound annual growth rates (CAGR) through 2026 (i.e., forecast period 2021 through 2026) and regional markets of infant nutrition devices. This report will highlight the current and future market potential for infant nutrition, as well as a detailed analysis of the competitive environment. It report will cover regulatory scenarios, drivers, restraints and opportunities. It also covers market projections for 2026 and the market shares for key market players.
Based on infant formulas, the market is segmented into specialized infant formulas and standard infant formulas. Based on nutrition type, the market is segmented into enteral and parenteral nutrition. The market is also segmented by powdered formula, concentrated liquid formula and ready-to-use formula.
The market has been segmented into various major geographic regions, including North America, Europe, Asia-Pacific and the Rest of the World. Detailed analysis of major countries (e.g., the U.S., Germany, the U.K., Japan, China, India) will be covered within the regional segment. For market estimates, data are provided using 2020 as the base year, with estimates for 2021 and forecast value for 2026.
A holistic study of the market has been carried out, incorporating various factors, including country-specific demographic conditions and business cycles, and market-specific microeconomic influences needed to analyze future market trends. Key vendor analysis, new products, developments and financials are also provided to enable easy decision making.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2020 | ||||||||||||||||||||||||||||
| Forecast period considered | 2021–2026 | ||||||||||||||||||||||||||||
| Base year market size | $44.4 billion | ||||||||||||||||||||||||||||
| Market size forecast | $61.5 billion | ||||||||||||||||||||||||||||
| Growth rate | CAGR of 6.5% from 2021 to 2026 | ||||||||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||||||||
| Segments covered | Type Of Infant Formula, Type Of Nutrition, Form | ||||||||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||||||||||||||||||
| Countries covered | U.S., Canada, Germany, U.K., France, Italy, Spain, Rest of Europe, China, India, Japan, Australia, South Korea, Rest of Asia-Pacific | ||||||||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||||||||
| Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets (HLC176E)
- Carbon Credits Market: Global Outlook (EGY200A)
- Drugs and Diagnostics for Hematological Disorders: Global Markets (PHM116C)
- Global Flame and Smoke Detectors Markets (MFG092A)
- Biodegradable Polymers: Global Markets and Technologies (PLS025K)
Related Reports
Sports Nutrition and High Energy Supplements: The Global Market
The global market for sports nutrition and high-energy supplements is estimated to increase from $37.0 billion in 2023 to reach $53.5 billion by 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.
Personalized Nutrition: Global Markets
The global personalized nutrition market reached $23.5 billion in 2022 and should reach $48.2 billion by 2028, with a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2023-2028.
Functional Foods and Beverages: Global Markets
The global market for functional food and beverages should grow from $216.4 billion in 2022 to $324.4 billion by 2027 with a compound annual growth rate (CAGR) of 8.4% for the period of 2022-2027.
Nutraceuticals: Global Markets to 2026
The global nutraceutical market should grow from $289.8 billion in 2021 to $438.9 billion by 2026, at compound annual growth rate (CAGR) of 8.7% for the period of 2021-2026.
Recent Reports
Drugs and Diagnostics for Hematological Disorders: Global Markets
The global market for drugs and diagnostics for hematological disorders is expected to grow from $131.2 billion in 2024 and is projected to reach $189.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.
Global Markets and Technologies for Advanced Drug Delivery Systems
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.
Chagas Disease: American trypanosomiasis Market
The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More